ACR 2022 Tweet by Julian Segan

An Italian retrospective study of 411 idiopathic inflammatory myopathies (IIM) patients applied IMACS criteria to assess the risk of cancer and found significantly more cancers in those at high risk.

Malignancy rivals cardiovascular disease as a leading cause of death in patients with systemic autoimmune diseases. Chronic inflammation and immune dysregulation can drive oncogenesis, while antitumor immune responses can trigger autoimmune phenomena (paraneoplastic syndromes, checkpoint inhibitor-induced rheumatic disease).

Dr. Jack Cush reviews this weeks news from RheumNow.com -- including placebo trumps controversial therapies, the dynamics of disease activity, fuze the big toe, and patients don’t appreciate being told “its all in your head”!